Search Results - "Schwartz, Robert P."

Refine Results
  1. 1

    Assessing the impact of jail-initiated medication for opioid use disorder: A multisite analysis of the SOMATICS collaborative by Lee, Joshua D, Goldfeld, Keith, Schwartz, Robert P, McDonald, Ryan, Xu, Yifan, Chandler, Redonna, Hallgren, Kevin, Kelly, Sharon M, Mitchell, Shannon Gwinn, Sharma, Anjalee, Farabee, David

    Published in PloS one (17-06-2024)
    “…The objective of this study was to estimate the associations of jail-initiated medication for opioid use disorder (MOUD) and patient navigation (PN) with…”
    Get full text
    Journal Article
  2. 2

    The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care by Gryczynski, Jan, Sanchez, Katherine, Carswell, Steven B, Schwartz, Robert P

    Published in Addiction science & clinical practice (16-11-2023)
    “…The TAPS Tool ("Tobacco, Alcohol, Prescription drug, and illicit Substance use") is a screening and brief assessment for detecting unhealthy substance use in…”
    Get full text
    Journal Article
  3. 3

    Leaving buprenorphine treatment: Patients' reasons for cessation of care by Gryczynski, Jan, Ph.D, Mitchell, Shannon Gwin, Ph.D, Jaffe, Jerome H., M.D, O’Grady, Kevin E., Ph.D, Olsen, Yngvild K., M.D, Schwartz, Robert P., M.D

    Published in Journal of substance abuse treatment (01-03-2014)
    “…Abstract Many opioid-dependent patients leave treatment prematurely. This study is a planned secondary analysis from a randomized trial of counseling for…”
    Get full text
    Journal Article
  4. 4

    Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff by Wu, Li-Tzy, Mannelli, Paolo, John, William S, Anderson, Alyssa, Schwartz, Robert P

    “…Abstract Background The US federal regulations allow pharmacy administration and dispensing of methadone for opioid use disorder (PADMOUD) to increase the…”
    Get full text
    Journal Article
  5. 5

    Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff by Mitchell, Shannon Gwin, Jester, Julia, Gryczynski, Jan, Whitter, Melanie, Fuller, Douglas, Halsted, Caroline, Schwartz, Robert P

    Published in Addiction science & clinical practice (17-10-2023)
    “…Abstract Background During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised…”
    Get full text
    Journal Article
  6. 6

    Polysubstance use and post-discharge mortality risk among hospitalized patients with opioid use disorder by Hochstatter, Karli R, Nordeck, Courtney, Mitchell, Shannon Gwin, Schwartz, Robert P, Welsh, Christopher, Gryczynski, Jan

    Published in Preventive medicine reports (01-12-2023)
    “…Polysubstance use is becoming increasingly common and presents several harms. This study aimed to examine the association of comorbid cocaine, alcohol (binge…”
    Get full text
    Journal Article
  7. 7

    Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S by Wu, Li-Tzy, John, William S, Mannelli, Paolo, Morse, Eric D, Anderson, Alyssa, Schwartz, Robert P

    Published in Addiction science & clinical practice (02-08-2023)
    “…Pharmacy administration and dispensing of methadone treatment for opioid use disorder (PADMOUD) may address inadequate capability of opioid treatment programs…”
    Get full text
    Journal Article
  8. 8

    Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial by Nordeck, Courtney D, Kelly, Sharon M, Schwartz, Robert P, Mitchell, Shannon G, Welsh, Christopher, O'Grady, Kevin E, Gryczynski, Jan

    Published in Addiction science & clinical practice (28-04-2024)
    “…Individuals with substance use disorders (SUDs) frequently use acute hospital services. The Navigation Services to Avoid Rehospitalization (NavSTAR) trial…”
    Get full text
    Journal Article
  9. 9
  10. 10

    rTMS in the Treatment of Drug Addiction : An Update about Human Studies by Manganotti, Paolo, Bellamoli, Elisa, Schwartz, Robert P., Rimondo, Claudia, Gomma, Maurizio, Serpelloni, Giovanni

    Published in Behavioural neurology (01-01-2014)
    “…Drug addiction can be a devastating and chronic relapsing disorder with social, psychological, and physical consequences, and more effective treatment options…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Development and use of a checklist for the implementation of medication for opioid use disorder in jails by Ludwig, Ariel, Monico, Laura B., Blue, Thomas, Gordon, Michael S., Schwartz, Robert P., Mitchell, Shannon Gwin

    Published in Implementation research and practice (01-01-2022)
    “…Background: In light of short lengths of stay and proximity to communities of release, jails are well-positioned to intervene in opioid use disorder (OUD)…”
    Get full text
    Journal Article
  14. 14

    Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service by Nordeck, Courtney D., Welsh, Christopher, Schwartz, Robert P., Mitchell, Shannon Gwin, O'Grady, Kevin E., Gryczynski, Jan

    Published in Drug and alcohol dependence reports (01-03-2022)
    “…•Hospital-based opioid agonist treatment (OAT) differed by sex, race, and housing status.•Hospital-based OAT was associated with linkage to community-based…”
    Get full text
    Journal Article
  15. 15

    Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine by Blue, Thomas R, Gordon, Michael S, Schwartz, Robert P, Couvillion, Kathryn, Vocci, Frank J, Fitzgerald, Terrence T, O'Grady, Kevin E

    Published in Addiction science & clinical practice (02-12-2019)
    “…It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Interim versus standard methadone treatment: A benefit–cost analysis by Schwartz, Robert P., M.D, Alexandre, Pierre K., Ph.D, Kelly, Sharon M., Ph.D, O'Grady, Kevin E., Ph.D, Gryczynski, Jan, Ph.D, Jaffe, Jerome H., M.D

    Published in Journal of substance abuse treatment (01-03-2014)
    “…Abstract A benefit–cost analysis was conducted as part of a clinical trial in which newly-admitted methadone patients were randomly assigned to interim…”
    Get full text
    Journal Article
  18. 18

    A Brief Screening Tool for Opioid Use Disorder: EMPOWER Study Expert Consensus Protocol by You, Dokyoung S, Mardian, Aram S, Darnall, Beth D, Chen, Chwen-Yuen A, De Bruyne, Korina, Flood, Pamela D, Kao, Ming-Chih, Karnik, Anita D, McNeely, Jennifer, Porter, Joel G, Schwartz, Robert P, Stieg, Richard L, Mackey, Sean C

    Published in Frontiers in medicine (31-03-2021)
    “…Growing concerns about the safety of long-term opioid therapy and its uncertain efficacy for non-cancer pain have led to relatively rapid opioid deprescribing…”
    Get full text
    Journal Article
  19. 19

    Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm by Mark, Katrina, Gryczynski, Jan, Axenfeld, Ellen, Schwartz, Robert P., Terplan, Mishka

    Published in Journal of addiction medicine (01-05-2017)
    “…OBJECTIVES:The objective of this study was to investigate pregnant womenʼs current use of cannabis and their intended patterns of use with relation to their…”
    Get full text
    Journal Article
  20. 20

    Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder : A Randomized Trial by Gryczynski, Jan, Nordeck, Courtney D, Welsh, Christopher, Mitchell, Shannon G, O'Grady, Kevin E, Schwartz, Robert P

    Published in Annals of internal medicine (01-07-2021)
    “…Hospitalized patients with comorbid substance use disorders (SUDs) are at high risk for poor outcomes, including readmission and emergency department (ED) use…”
    Get full text
    Journal Article